This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...